Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-17

Clinical Trial Update: Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma [NA]

View source ↗

Summary

A completed clinical trial comparing the Baerveldt 350 glaucoma drainage implant with the Ahmed ClearPath 250 implant for glaucoma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ahmed ClearPath 250
  • Baerveldt 350

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Glaucoma | NA | Status: COMPLETED | Results posted: 2026-04-17